Want to see IN:PPLPHARMA full AI Analyst Report?
Piramal Pharma Limited (PPLPHARMA) Income Statement
Piramal Pharma Limited Income Statement
Last quarter (Q1 2027), Piramal Pharma Limited's total revenue was $22.70B, an increase of 17.39% from the same quarter last year. In Q1, Piramal Pharma Limited's net income was $-693.90M. See Piramal Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 88.69B | $ 90.61B | $ 81.06B | $ 70.32B | $ 64.72B | |
| $ 23.83B | $ 54.89B | $ 48.48B | $ 40.32B | $ 37.91B | |
| $ 22.93B | $ 48.10B | $ 43.86B | $ 40.80B | $ 34.26B | |
| Depreciation and Amortization | $ 8.31B | $ 8.16B | $ 7.41B | $ 6.77B | $ 5.86B |
| $ 9.96B | $ 16.49B | $ 13.67B | $ 8.94B | $ 12.60B | |
| $ 903.80M | $ 6.79B | $ 4.62B | $ -479.70M | $ 3.65B | |
| $ -2.66B | $ -2.64B | $ -2.83B | $ -721.80M | $ 1.20B | |
| $ -1.76B | $ 4.15B | $ 1.79B | $ -1.20B | $ 4.85B | |
| $ -3.26B | $ 911.30M | $ 178.20M | $ -1.86B | $ 3.76B | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.46 | $ 0.69 | $ 0.14 | $ -1.54 | $ 3.09 |
| Diluted EPS | $ -2.46 | $ 0.68 | $ 0.14 | $ -1.54 | $ 3.09 |
| Weighted Average Shares Outstanding | 1.32B | 1.34B | 1.27B | 1.21B | 1.22B |
| Weighted Average Shares Outstanding (Diluted) | 1.32B | 1.34B | 1.28B | 1.21B | 1.22B |
Currency in INR
